| Financial Year |
March 31 2023 |
| Monetary Funds |
11,910,513,795.76 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
346,503,094.50 |
| Accounts Receivable |
7,538,862,194.68 |
| Advances to Suppliers |
88,477,836.78 |
| Other Receivables |
62,894,706.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,155,113,055.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,361,121,909.44 |
| Total Current Assets |
27,998,830,270.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
26,659,180,201.10 |
| Investment Properties |
-- |
| Fixed Assetes |
7,913,860,715.71 |
| Under-construction Projects |
4,128,133,547.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,731,358,659.47 |
| R&D expenses |
-- |
| Goodwill |
416,100,700.47 |
| Long-Term Deferred and Prepaid Expenses |
3,500,021.60 |
| Deferred Income Tax Assets |
1,913,526,355.67 |
| Other Non-Current Assets |
117,949,931.44 |
| Sub-Total of Non-Current Assets |
47,059,035,725.34 |
| Total Assets |
75,057,865,996.10 |
| Short-Term Loans |
45,414,628.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
357,749,974.35 |
| Accounts Payable |
2,548,123,318.82 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
122,361,525.26 |
| Taxes Payable |
5,059,537,408.33 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
13,809,141.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
71,601,635.29 |
| Other Current Liabilities |
124,989,698.82 |
| Sub-Total of Current Liabilities |
8,561,423,859.74 |
| Long-term Loans |
8,654,013,322.84 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
268,989,810.76 |
| Deferred Income Tax Liabilities |
1,470,404,158.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,753,278,679.57 |
| Total Liabilities |
19,314,702,539.31 |
| Paid-In Capital(Or Share Stock) |
1,641,221,583.00 |
| Capital Surplus |
23,303,717,163.67 |
| Surplus Reserve |
831,954,051.59 |
| LESS:Treasury Stock |
199,985,012.86 |
| Undistributed Profits |
27,913,097,332.25 |
| Minority Stockholder's Interest |
2,760,364,947.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
52,982,798,509.57 |
| Owner's Equity（Stockholder's Equity） |
55,743,163,456.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
75,057,865,996.10 |
